Use of flavone derivatives for gastroprotection
    1.
    发明授权
    Use of flavone derivatives for gastroprotection 失效
    使用黄酮衍生物进行胃保护

    公开(公告)号:US5399584A

    公开(公告)日:1995-03-21

    申请号:US15771

    申请日:1993-02-10

    摘要: The subject invention relates to methods for preventing or treating damage to the mucosal lining of the gastrointestinal tract of a human or lower animal by administering a safe and effective amount of a compound having the structure: ##STR1## wherein X and Y are each independently selected from O and S; R.sup.1, R.sup.2 and R.sup.3 are each independently selected from hydrogen, hydroxy, halo, unsubstituted or monosubstituted straight or branched C.sub.1 -C.sub.4 alkanyl, and unsubstituted or substituted straight or branched C.sub.1 -C.sub.4 alkanoxy; and each of R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is hydrogen or, if one or more of R.sup.1, R.sup.2 and R.sup.3 is other than hydrogen, each of R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is selected from hydrogen, halo, trifluoromethyl, and unsubstituted straight or branched C.sub.1 -C.sub.4 alkanyl.

    摘要翻译: 本发明涉及通过施用安全有效量的具有以下结构的化合物来预防或治疗对人或其以下动物的胃肠道粘膜的损伤的方法:其中X和Y各自独立地选择 从O和S; R 1,R 2和R 3各自独立地选自氢,羟基,卤素,未取代或单取代的直链或支链C 1 -C 4烷基,以及未取代或取代的直链或支链C 1 -C 4烷氧基; R 4,R 5,R 6和R 7各自为氢,或者如果R 1,R 2和R 3中的一个或多个不是氢,则R 4,R 5,R 6和R 7各自选自氢,卤素,三氟甲基和未取代的直链 或支链C 1 -C 4烷基。

    Alkanoarachidonic acids
    2.
    发明授权
    Alkanoarachidonic acids 失效
    藻糖酸

    公开(公告)号:US4759880A

    公开(公告)日:1988-07-26

    申请号:US655196

    申请日:1984-09-27

    摘要: A series of alkanoarachidonic acids have been prepared as modulators of the arachidonic acid cascade to increase the production of biologically desirable compounds and minimize the production of biologically undesirable compounds. Examples of desirable compounds in this respect comprise postaglandins and thromboxanes whereas undesirable compounds comprise the mono- and polyhydroxyarachidonic acids and leukotrienes. The alkanoarachidonic acids and their intermediates are of the general formula: ##STR1## and at least one of X, Y, and Z is lower alkano and is hydrogen when not lower alkano; the esters and salts of the acids are also prepared. The acids, esters and salts may be used as anti-anaphylaxis or anti-thrombosis agents.

    摘要翻译: 已经制备了一系列链烷二糖酸作为花生四烯酸级联的调节剂,以增加生物需要的化合物的产生并使生物学不需要的化合物的产生最小化。 所需化合物在这方面的实例包括Postaglandin和血栓素,而不希望的化合物包括单羟基和多羟基花生四烯酸和白三烯。 链烷二酸及其中间体具有以下通式:其中R 1 =低级烷基(低级烷基)(低级亚烷基)OH(低级亚烷基)CHO CHO,其中R 2 = COO(低级烷基)(低级烷基) 亚烷基)OH(低级亚烷基)CHO CHO其中R3 = COO(低级烷基)(低级亚烷基)OH(低级亚烷基)CHO CHO,X,Y和Z中的至少一个为低级烷基,当不为 低级烷 还制备了酸的酯和盐。 酸,酯和盐可用作抗过敏反应或抗血栓形成剂。

    Sulfated glyceroglucolipids as inhibitors of bacterial adherence
    3.
    发明授权
    Sulfated glyceroglucolipids as inhibitors of bacterial adherence 失效
    硫酸化甘油糖脂作为细菌粘附抑制剂

    公开(公告)号:US5116821A

    公开(公告)日:1992-05-26

    申请号:US616285

    申请日:1990-11-20

    IPC分类号: A61K31/70 C07H3/06 C07H15/04

    CPC分类号: C07H15/04 A61K31/70 C07H3/06

    摘要: The subject invention involves pharmaceutical compositions comprising a sulfated glyceroglucolipid having the structure: ##STR1## wherein n is an integer of from 1 to about 5, R is hydrogen or C.sub.1 -C.sub.24 acyl or alkyl, R' is hydrogen or C.sub.1 -C.sub.24 acyl or alkyl, and M.sup.+ is a cationic moiety, and methods of treating or preventing gastroduodenal diseases or disorders caused by or associated with H. pylori by administering such compounds.

    摘要翻译: 本发明涉及包含具有以下结构的硫酸化甘油糖脂的药物组合物:其中n为1至约5的整数,R为氢或C 1 -C 24酰基或烷基,R 1为氢或C1- C24酰基或烷基,M +是阳离子部分,以及通过施用这些化合物治疗或预防由胃幽门螺杆菌引起或与之相关的胃十二指肠疾病或病症的方法。